Medpace Holdings, Inc. (MEDP)
602.89
-17.62
(-2.84%)
USD |
NASDAQ |
Oct 06, 16:00
602.89
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Enterprise Value : 16.92B for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 16.92B |
| October 02, 2026 | 16.33B |
| October 01, 2026 | 16.29B |
| September 30, 2026 | 17.02B |
| September 29, 2026 | 16.96B |
| September 28, 2026 | 16.79B |
| September 25, 2026 | 16.87B |
| September 24, 2026 | 16.92B |
| September 23, 2026 | 16.82B |
| September 22, 2026 | 17.19B |
| September 21, 2026 | 17.02B |
| September 18, 2026 | 16.69B |
| September 17, 2026 | 16.77B |
| September 16, 2026 | 16.80B |
| September 15, 2026 | 16.92B |
| September 14, 2026 | 16.22B |
| September 11, 2026 | 16.00B |
| September 10, 2026 | 15.88B |
| September 09, 2026 | 15.96B |
| September 08, 2026 | 16.09B |
| September 04, 2026 | 16.10B |
| September 03, 2026 | 16.16B |
| September 02, 2026 | 16.15B |
| September 01, 2026 | 15.88B |
| August 31, 2026 | 16.18B |
| Date | Value |
|---|---|
| August 28, 2026 | 16.36B |
| August 27, 2026 | 16.67B |
| August 26, 2026 | 16.88B |
| August 25, 2026 | 16.74B |
| August 24, 2026 | 16.90B |
| August 21, 2026 | 16.92B |
| August 20, 2026 | 16.70B |
| August 19, 2026 | 16.58B |
| August 18, 2026 | 16.08B |
| August 17, 2026 | 16.27B |
| August 14, 2026 | 15.75B |
| August 13, 2026 | 15.84B |
| August 12, 2026 | 16.26B |
| August 11, 2026 | 16.50B |
| August 10, 2026 | 16.41B |
| August 07, 2026 | 16.09B |
| August 06, 2026 | 15.93B |
| August 05, 2026 | 16.00B |
| August 04, 2026 | 15.65B |
| August 03, 2026 | 15.60B |
| July 31, 2026 | 15.71B |
| July 30, 2026 | 15.74B |
| July 29, 2026 | 15.93B |
| July 28, 2026 | 15.54B |
| July 27, 2026 | 16.05B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 58.09B |
| Charles River Laboratories International, Inc. | 17.70B |
| Avantor, Inc. | 14.09B |
| Champions Oncology, Inc. | 76.35M |
| Personalis, Inc. | 1.570B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 121.36M |
| Revenue (Quarterly) | 707.33M |
| Total Expenses (Quarterly) | 585.97M |
| EPS Diluted (Quarterly) | 4.250 |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 17.16% |
| Earnings Yield | 2.83% |
| Operating Earnings Yield | 3.36% |
| Normalized Earnings Yield | 2.828 |